New Jersey-based pharmaceutical company Sanofi-aventis has agreed to acquire rival BiPar Sciences for an undisclosed sum
Related Topics
Early Stage Funding
New Jersey-based pharmaceutical company Sanofi-aventis has agreed to acquire rival BiPar Sciences for an undisclosed sum